Literature DB >> 12166501

Immunomodulatory effects of glatiramer acetate on superantigen- and mitogen-induced T-cell stimulation in vitro.

S Schmidt1, S Balzer, C Nüllen, M Schmidt, C Pohl, A von Rücker, T Klockgether.   

Abstract

Glatiramer acetate (GA) interferes with antigen recognition and modulates cytokine secretion of T cells in an antigen-specific manner. Here we analysed the capacity of GA to modulate proliferative responses and cytokine secretion of peripheral blood mononuclear cells (PBMCs) in response to antigen-independent stimuli, i.e., phytohaemagglutinin (PHA) and staphylococcal enterotoxin B (SEB) stimulation in five healthy volunteers. A significant reduction of proliferative responses, as well as interferon-gamma (IFNalpha) and tumour necrosis factor-alpha (TNFalpha) secretion, was observed at concentrations of 200 microg/ml suggesting that GA may also exert immunomodulatory effects on mitogen- and superantigen-induced T-cell stimulation in vitro. However, since systemic GA concentrations of this magnitude are highly unlikely to occur in vivo the immunomodulatory effects observed here are not likely to contribute to the therapeutic mechanisms of action under physiological conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12166501     DOI: 10.1191/1352458502ms818sr

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  2 in total

1.  Identification of NAD+ synthetase from Streptococcus sobrinus as a B-cell-stimulatory protein.

Authors:  Isabel Veiga-Malta; Margarida Duarte; Márcia Dinis; Pedro Madureira; Paula Ferreira; Arnaldo Videira
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

2.  The influence of glatiramer acetate on Th17-immune response in multiple sclerosis.

Authors:  Mikhail Melnikov; Svetlana Sharanova; Anastasiya Sviridova; Vladimir Rogovskii; Nina Murugina; Anna Nikolaeva; Yulia Dagil; Vladimir Murugin; Tatiana Ospelnikova; Alexey Boyko; Mikhail Pashenkov
Journal:  PLoS One       Date:  2020-10-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.